Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about NVS

Recent news which mentions NVS

< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Why Is European Pharma Giant Novartis Stock Trading Lower Today?
Tickers NEWS NVS
Tags Trading Ideas Earnings Health Care
From Benzinga
Nasdaq Futures Plummet As Alphabet, AMD Disappointments Sour Sentiment; Spotlight Shifts To Fed Statement, Powell's Presser
Tickers AMD BA BSX CHRW
Tags QQQ Top Stories MSFT
From Benzinga
Alphabet Reports Q4 Results, Joins AMD, Tesla And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Tickers AMD AMSC BITF BTDR
Tags Small Cap Benzinga big losers
From Benzinga
Earnings Scheduled For January 31, 2024
Tickers ADP AFL ALGN APTV
Tags MTH MHO GTIM
From Benzinga
3 Hidden Healthcare Stocks Poised for a Breakout This Year
Tickers MCK NVS
Tags NVS MCK Market News
From InvestorPlace
Earnings Outlook For Novartis
Tickers NVS
Tags Earnings Benzinga NVS
From Benzinga
Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism?
Tickers AAPL ABBV AMD AMZN
Tags EAT NUE BMY
From Benzinga
Gilead's Tecartus Dropped From FDA List Of CAR-T Therapy With Updated Label Warning Of "Risks Of Secondary Cancer'
Tickers BMY GILD JNJ NEWS
Tags BMY GILD NVS
From Benzinga
Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment
Tickers AZN BMY GILD GRCL
Tags LEGN General FDA
From Benzinga
Cytokinetics' Heart Drug Is A Multi-Billion Dollar Opportunity By 2032 Despite Novartis Setback: Analyst
Tickers AZN BMY CYTK NEWS
Tags BMY AZN NVS
From Benzinga
Novartis Retreats From Cytokinetics Deal, Dashing Hopes For Multi-Billion Dollar Acquisition
Tickers CYTK NEWS NVS
Tags CYTK NVS Market News
From Benzinga
What's Been Happening With Cytokinetics Stock?
Tickers CYTK NEWS NVS
Tags why it's moving News Movers
From Benzinga
Why Is Heart Failure Drug-Focused Cytokinetic Stock Trading Higher Today?
Tickers CYTK NEWS NVS
Tags Movers Biotech Benzinga
From Benzinga
Why Is $7B Valued Cancer Focused Exelixis Trading Lower Today?
Tickers EXEL MRK NEWS NVS
Tags Health Care Earnings Trading Ideas
From Benzinga
Google's AI Spin-Off Isomorphic Labs Strikes Big Pharma Deals, Paving the Way for Future of Drug Discovery
Tickers GOOG GOOGL LLY NEWS
Tags AI Generated GOOG LLY
From Benzinga
(NVS) - Analyzing Novartis's Short Interest
Tickers NVS
Tags BZI/SHORTHIST Market News NVS
From Benzinga
Voyager Therapeutics Stock Tanked After-Hours - Here's Why
Tickers NEWS NVS VYGR
Tags Benzinga After/Hours Center Movers
From Benzinga
Big Players' Recent Trades in NVS Options
Tickers NVS
Tags Markets Market News NVS
From Benzinga
VYGR Stock Alert: The $1.2 Billion Reason Voyager Therapeutics Is Up Today
Tickers AZN NBIX NVS VYGR
Tags Today's Market NBIX VYGR
From InvestorPlace
Why Is Gene Therapy Focused Voyager Therapeutics Stock Soaring Today?
Tickers NEWS NVS VYGR
Tags NVS Market News VYGR
From Benzinga
Why Is Neurology Focused Cingulate Stock Trading Higher Today?
Tickers CING NEWS NVS
Tags Biotech Movers Benzinga
From Benzinga
Why Is Cytokinetics (CYTK) Stock Up 70% Today?
Tickers AZN BMY CYTK NVS
Tags Today's Market NASDAQ:CYTK,NYSE:BMY,NYSE:NVS,NASDAQ:AZN AZN
From InvestorPlace
These 3 Big Pharma Stocks Are Making Big Plays With AI
Tickers AZN LLY NVS
Tags AZN LLY Market News
From Motley Fool
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
Tickers CALT MCK NVS RHHBY
Tags MCK General Small Cap
From Benzinga
Fusion's Pharma's Targeted Cancer Therapy Potential Gets This Analyst Bullish, Sees 100% Upside
Tickers AZN FUSN NVS
Tags News FUSN Trading Ideas
From Benzinga
(NVS) - Analyzing Novartis's Short Interest
Tickers NVS
Tags Benzinga Trading Ideas Short Ideas
From Benzinga
Lantheus Downgraded Due To Reliance On PNT2002; Analyst Cites Comparable Profile To Novartis' Drug
Tickers LNTH NVS PNT
Tags Analyst Ratings NVS Market News
From Benzinga
Are November’s 3 Biggest Stock Losers Worth Snapping Up Now?
Tickers ECX FSR FTRE GELYF
Tags FTRE MBLY VLVLY
From InvestorPlace
FDA Approves Merck's Drug Belzutifan For Type Of Advanced Kidney Cancer In Pretreated Cancer Patients
Tickers MRK NVS
Tags Market News NVS FDA
From Benzinga
Novartis' Newly FDA-Approved Rare Blood Disorder Drug Aces Phase 3 Study In Ultra Rare Kidney Failure Disease
Tickers NVS
Tags General NVS Market News
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.